CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation

被引:166
作者
Pan, C
Baumgarth, N
Parnes, JR [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA
关键词
D O I
10.1016/S1074-7613(00)80124-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD72, a B cell surface protein of the C-type lectin superfamily, recruits the tyrosine phosphatase SHP-1 through its ITIM motif(s). Using CD72-deficient (CD72(-/-)) mice, we demonstrate that CD72 is a nonredundant regulator of B cell development. In the bone marrow of CD72(-/-) mice, there was a reduction in the number of mature recirculating B cells and an accumulation of pre-B cells. In the periphery of CD72(-/-) mice, there were fewer mature B-2 cells and more B-l cells. In addition, CD72 is a negative regulator of B cell activation, as CD72(-/-) B cells were hyperproliferative in response to various stimuli and showed enhanced kinetics in their intracellular Ca2+ response following IgM cross-linking.
引用
收藏
页码:495 / 506
页数:12
相关论文
共 58 条
[1]  
Adachi T, 1998, J IMMUNOL, V160, P4662
[2]   Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen [J].
Ahearn, JM ;
Fischer, MB ;
Croix, D ;
Goerg, S ;
Ma, MH ;
Xia, JR ;
Zhou, XN ;
Howard, RG ;
Rothstein, TL ;
Carroll, MC .
IMMUNITY, 1996, 4 (03) :251-262
[3]  
ALLMAN DM, 1993, J IMMUNOL, V151, P4431
[4]  
BUTCHER EC, 1982, J IMMUNOL, V129, P2698
[5]  
CAMPBELL MA, 1995, SCAND J IMMUNOL, V41, P563
[6]   TRANSITIONAL B-CELLS ARE THE TARGET OF NEGATIVE SELECTION IN THE B-CELL COMPARTMENT [J].
CARSETTI, R ;
KOHLER, G ;
LAMERS, MC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06) :2129-2140
[7]   PROTEIN-TYROSINE-PHOSPHATASE 1C NEGATIVELY REGULATES ANTIGEN RECEPTOR SIGNALING IN B-LYMPHOCYTES AND DETERMINES THRESHOLDS FOR NEGATIVE SELECTION [J].
CYSTER, JG ;
GOODNOW, CC .
IMMUNITY, 1995, 2 (01) :13-24
[8]   A ROLE IN B-CELL ACTIVATION FOR CD22 AND THE PROTEIN-TYROSINE-PHOSPHATASE SHP [J].
DOODY, GM ;
JUSTEMENT, LB ;
DELIBRIAS, CC ;
MATTHEWS, RJ ;
LIN, JJ ;
THOMAS, ML ;
FEARON, DT .
SCIENCE, 1995, 269 (5221) :242-244
[9]  
EGAN SE, 1993, NATURE, V363, P83
[10]   ABNORMAL B-LYMPHOCYTE DEVELOPMENT, ACTIVATION, AND DIFFERENTIATION IN MICE THAT LACK OR OVEREXPRESS THE CD19 SIGNAL-TRANSDUCTION MOLECULE [J].
ENGEL, P ;
ZHOU, LJ ;
ORD, DC ;
SATO, S ;
KOLLER, B ;
TEDDER, TF .
IMMUNITY, 1995, 3 (01) :39-50